T. Rowe Price Investment Management »

Prelude Therapeutics shares owned by T. Rowe Price Investment Management

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by T. Rowe Price Investment Management from 13F filings

Historical chart of T. Rowe Price Investment Management investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by T. Rowe Price Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by T. Rowe Price Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $583k 282k 2.07

More positions owned by T. Rowe Price Investment Management

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Fortive Corp Comm Stk (FTV)
Amazon Comm Stk (AMZN)
PTC Comm Stk (PTC)
Unitedhealth Group Comm Stk (UNH)
Revvity Comm Stk (RVTY)
Danaher Corporation Comm Stk (DHR)
Becton Dickinson & Co Comm Stk (BDX)
Roper Technologies Comm Stk (ROP)
Marvell Technology Comm Stk (MRVL)
Martin Marietta Matls Comm Stk (MLM)
Alphabet Comm Stk (GOOGL)
Apple Comm Stk (AAPL)
Hologic Comm Stk (HOLX)

View all positions for T. Rowe Price Investment Management

Top funds holding Prelude Therapeutics

OrbiMed Advisors
Baker Bros. Advisors
Deerfield Management Company
Boxer Capital
T. Rowe Price Associates
BlackRock
BlackRock
Vanguard Group
ExodusPoint Capital Management
Avidity Partners Management
Massachusetts Financial Services
Geode Capital Management
Marshall Wace
Sio Capital Management
Morgan Stanley

View all funds holding Prelude Therapeutics